000 03391nam a22006497a 4500
008 240723s20242024 xxu||||| |||| 00| 0 eng d
022 _a1522-1946
040 _aOvid MEDLINE(R)
099 _a38605682
245 _aA novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique. [Review]
251 _aCatheterization & Cardiovascular Interventions. 103(6):917-923, 2024 May.
252 _aCatheter Cardiovasc Interv. 103(6):917-923, 2024 May.
253 _aCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
260 _c2024
260 _p2024 May
260 _fFY2024
265 _sppublish
265 _tMEDLINE
501 _aAvailable online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006
520 _aThe advent of excimer laser coronary atherectomy (ELCA) nearly four decades ago heralded a novel way to treat complex lesions, both coronary and peripheral, which were previously untraversable and thus untreatable. These complex lesions include heavily calcified lesions, ostial lesions, bifurcation lesions, chronic total occlusions, in-stent restenosis (including stent underexpansion), and degenerative saphenous vein grafts. We discuss the technology of ELCA, its indications, applications, and complications, and suggest the "MAXCon ELCA" technique for better outcomes without increased risk. Lastly, we present a case of MAXCon ELCA effectively treating a complex lesion. Copyright © 2024 Wiley Periodicals LLC.
546 _aEnglish
650 _a*Atherectomy, Coronary
650 _a*Coronary Angiography
650 _a*Coronary Artery Disease
650 _a*Lasers, Excimer
650 _aAged
650 _aContrast Media
650 _aCoronary Artery Disease/dg [Diagnostic Imaging]
650 _aCoronary Artery Disease/th [Therapy]
650 _aHumans
650 _aLasers, Excimer/tu [Therapeutic Use]
650 _aMale
650 _aSaline Solution/ad [Administration & Dosage]
650 _aTreatment Outcome
650 _zAutomated
651 _aMedStar Heart & Vascular Institute
651 _aMedStar Heart & Vascular Institute
_bMHVI
651 _aMedStar Washington Hospital Center
656 _aCardiovascular Disease Fellowship
657 _aCase Reports
657 _aJournal Article
657 _aReview
700 _aBazarbashi, Najdat
_bMWHC
_cCardiovascular Disease Fellowship
_dMBBS
700 _aBen-Dor, Itsik
_bMHVI
700 _aBernardo, Nelson L
_bMHVI
700 _aCase, Brian C
_bMHVI
700 _aGallino, Robert
700 _aHashim, Hayder
_bMHVI
700 _aRogers, Toby
_bMHVI
700 _aSatler, Lowell F
_bMHVI
700 _aWaksman, Ron
_bMHVI
790 _aCase BC, Bazarbashi N, Johnson A, Rogers T, Ben-Dor I, Satler LF, Waksman R, Hashim HD, Gallino R, Bernardo NL
856 _uhttps://dx.doi.org/10.1002/ccd.31037
_zhttps://dx.doi.org/10.1002/ccd.31037
858 _ySatler, Lowell F
_uhttp://orcid.org/0000-0001-6446-2683
_zhttp://orcid.org/0000-0001-6446-2683
_zhttp://orcid.org/0000-0002-4063-9226
858 _yWaksman, Ron
_uhttp://orcid.org/0000-0002-4063-9226
_zhttp://orcid.org/0000-0001-6446-2683
_zhttp://orcid.org/0000-0002-4063-9226
942 _cART
_dArticle
999 _c14288
_d14288